Vassilios Ladis

The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study

Vasilios Berdoukas, Giorgos Chouliaras, Panagiotis Moraitis et al. · Journal of Cardiovascular Magnetic Resonance · 2009 · 87 citations · Full text

Anemia, Hepatic Iron, Heart Failure +10

Iron chelation treatment with combined therapy with deferiprone and deferioxamine: A 12-month trial

Antonis Kattamis, Vassilios Ladis, Helen Berdousi et al. · Blood Cells Molecules and Diseases · 2006 · 85 citations

Iron Chelation Treatment, 12-Month Trial, Medicine +3

A prospective randomized controlled trial on the safety and efficacy of alternating deferoxamine and deferiprone in the treatment of iron overload in patients with thalassemia.

Renzo Galanello, Antonis Kattamis, Antonio Piga et al. · PubMed · 2006 · 80 citations

Adverse Events, Alternating Therapy, Iron Metabolism +9

Magnetic resonance evaluation of liver and myocardial iron deposition in thalassemia intermedia and b-thalassemia major

Sophie Mavrogeni, Efstathios D. Gotsis, Vassilios Ladis et al. · International journal of cardiac imaging · 2008 · 49 citations

Magnetic Resonance Evaluation, Thalassemia Intermedia, Myocardial Iron Deposition +7

Erythroid bone marrow activity and red cell hemoglobinization in iron sufficient beta-thalassemia heterozygotes as reflected by soluble transferrin receptor and reticulocyte hemoglobin in content. Correlation with genotypes and Hb A(2) levels.

Christophille Skarmoutsou, Ioannis Papassotiriou, Joanne Traeger‐Synodinos et al. · PubMed · 2003 · 40 citations